You are here: vision-research.eu » News » Newsdetails:

Research paves the way for new anti-fibrotic therapy for glaucoma

Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.